Development of the nephrotic syndrome during treatment of Crohn's disease with adalimumab

We report a patient with Crohn's disease who presented with renal insufficiency and the nephrotic syndrome after initiating therapy with adalimumab. Renal biopsy showed stages 2 to 3 membranous glomerulonephritis, and immunostaining showed glomerular deposition of immunoglobulin G and C3. The p...

Celý popis

Podrobná bibliografie

Vydáno v:	Journal of clinical gastroenterology Ročník 45; číslo 3; s. e30
Hlavní autoři:	Gupta, Alok, Pendyala, Prashant, Arora, Pradeep, Sitrin, Michael D
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.03.2011
Témata:	Adalimumab Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Crohn Disease - complications Crohn Disease - drug therapy Humans Male Middle Aged Nephrotic Syndrome - chemically induced Nephrotic Syndrome - physiopathology
ISSN:	1539-2031, 1539-2031
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!